X
NUVB icon

Xponance’s Nuvation Bio NUVB Stock Holding History

Xponance’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$137K Buy
24,158
+2,123
+10% +$10.4K ﹤0.01% 1679
2026
Q1 		$94.5K Buy
22,035
+3,079
+16% +$17.2K ﹤0.01% 1577
2025
Q4 		$170K Sell
18,956
-458
-2% -$2.84K ﹤0.01% 1415
2025
Q3 		$71.8K Buy
19,414
+80
+0.4% +$218 ﹤0.01% 1463
2025
Q2 		$37.7K Buy
19,334
+6,207
+47% +$12.9K ﹤0.01% 1472
2025
Q1 		$23.1K Buy
13,127
+684
+5% +$1.56K ﹤0.01% 1419
2024
Q4 		$33.1K Buy
12,443
+1,092
+10% +$2.81K ﹤0.01% 1417
2024
Q3 		$26K Hold
11,351
– – ﹤0.01% 1373
2024
Q2 		$33.1K Buy
+11,351
New +$34.6K ﹤0.01% 1293

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Xponance's NUVB Position: Q2 2026 in Review

Xponance increased its Nuvation Bio (NUVB) stake by 9.6% in Q2 2026, buying an estimated $10.4K and bringing the position to 24,158 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #1679.

Xponance first reported a position in NUVB in Q2 2024 and has held it in 9 quarters since. The position peaked at $170K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Xponance held 24,158 shares of Nuvation Bio worth $137K as of Q2 2026.
  • Xponance bought 2,123 Nuvation Bio shares in Q2 2026, an estimated $10.4K.
  • Nuvation Bio made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1679 holding.
  • Xponance first reported a position in Nuvation Bio in Q2 2024 and has held it in 9 quarters since.
  • Xponance's Nuvation Bio position peaked at $170K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.